Ekso Bionics Correlations
| EKSO Stock | USD 1.21 0.07 5.47% |
The correlation of Ekso Bionics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ekso Bionics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ekso Bionics Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Good diversification
The correlation between Ekso Bionics Holdings and NYA is -0.07 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Ekso Bionics Holdings and NYA in the same portfolio, assuming nothing else is changed.
Ekso |
The ability to find closely correlated positions to Ekso Bionics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ekso Bionics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ekso Bionics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ekso Bionics Holdings to buy it.
Moving together with Ekso Stock
| 0.85 | EMBC | Embecta Corp Financial Report 10th of May 2024 | PairCorr |
| 0.62 | AHG | Akso Health Group | PairCorr |
| 0.89 | IVP | Inspire Veterinary | PairCorr |
| 0.85 | TFX | Teleflex Incorporated Financial Report 2nd of May 2024 | PairCorr |
Moving against Ekso Stock
| 0.79 | ELMD | Electromed | PairCorr |
| 0.74 | GCTK | GlucoTrack | PairCorr |
| 0.71 | BAX | Baxter International Financial Report 25th of April 2024 | PairCorr |
| 0.68 | ALC | Alcon AG Financial Report 14th of May 2024 | PairCorr |
| 0.67 | FEMY | Femasys Financial Report 9th of May 2024 | PairCorr |
| 0.61 | CAH | Cardinal Health Financial Report 2nd of May 2024 | PairCorr |
| 0.5 | RMD | ResMed Inc Earnings Call This Week | PairCorr |
| 0.44 | COO | Cooper Companies Financial Report 6th of June 2024 | PairCorr |
| 0.44 | VMD | Viemed Healthcare | PairCorr |
| 0.93 | SNDA | Sonida Senior Living | PairCorr |
| 0.86 | TNDM | Tandem Diabetes Care Financial Report 1st of May 2024 | PairCorr |
| 0.85 | HIMS | Hims Hers Health Financial Report 13th of May 2024 | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Ekso Stock performing well and Ekso Bionics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Ekso Bionics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| A | 1.20 | (0.06) | (0.02) | 0.02 | 1.44 | 2.26 | 6.31 | |||
| ILMN | 1.82 | (0.34) | 0.00 | (0.09) | 0.00 | 3.65 | 9.89 | |||
| WAT | 1.39 | (0.18) | 0.00 | (0.03) | 0.00 | 2.55 | 7.95 | |||
| TMO | 0.93 | (0.08) | (0.05) | 0.00 | 1.28 | 1.80 | 6.87 | |||
| MTD | 1.36 | (0.09) | (0.02) | 0.01 | 1.82 | 2.48 | 6.80 | |||
| CRL | 1.50 | 0.02 | 0.06 | 0.07 | 1.57 | 2.87 | 15.05 | |||
| GH | 2.78 | (0.57) | 0.00 | (0.22) | 0.00 | 5.82 | 22.73 | |||
| RVTY | 1.24 | (0.23) | 0.00 | (0.07) | 0.00 | 2.09 | 8.67 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Ekso Bionics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Competition Analyzer Now
Competition AnalyzerAnalyze and compare many basic indicators for a group of related or unrelated entities |
| All Next | Launch Module |
Ekso Bionics Corporate Directors
Ekso Bionics corporate directors refer to members of an Ekso Bionics board of directors. The board of directors generally takes responsibility for the Ekso Bionics' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Ekso Bionics' board members must vote for the resolution. The Ekso Bionics board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Howard Palefksy | Director | Profile | |
| Dan Boren | Independent Director | Profile | |
| Stanley Stern | Independent Director | Profile | |
| Theodore Wang | Director | Profile |
Already Invested in Ekso Bionics Holdings?
The danger of trading Ekso Bionics Holdings is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Ekso Bionics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Ekso Bionics. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Ekso Bionics Holdings is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Ekso Bionics Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ekso Bionics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ekso Bionics Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ekso Bionics Holdings Stock: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Ekso Bionics Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Complementary Tools for Ekso Stock analysis
When running Ekso Bionics' price analysis, check to measure Ekso Bionics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ekso Bionics is operating at the current time. Most of Ekso Bionics' value examination focuses on studying past and present price action to predict the probability of Ekso Bionics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ekso Bionics' price. Additionally, you may evaluate how the addition of Ekso Bionics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Stocks Directory Find actively traded stocks across global markets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
Is Ekso Bionics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ekso Bionics. If investors know Ekso will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ekso Bionics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.10) | Revenue Per Share 1.318 | Quarterly Revenue Growth 0.365 | Return On Assets (0.27) | Return On Equity (0.80) |
The market value of Ekso Bionics Holdings is measured differently than its book value, which is the value of Ekso that is recorded on the company's balance sheet. Investors also form their own opinion of Ekso Bionics' value that differs from its market value or its book value, called intrinsic value, which is Ekso Bionics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ekso Bionics' market value can be influenced by many factors that don't directly affect Ekso Bionics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ekso Bionics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ekso Bionics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ekso Bionics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.